share_log

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

Vertex Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Bozic Carmen

福泰製藥 | 4：持股變動聲明-高管 Bozic Carmen
美股sec公告 ·  06/29 04:09
牛牛AI助理已提取核心訊息
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
Carmen Bozic, EVP and CMO of Vertex Pharmaceuticals Inc. (VRTX), completed a sale of 2,280 shares of common stock on June 26, 2024. The transaction was executed at a price of $471.72 per share, resulting in a total sale value of $1,075,521.60. Following the sale, Bozic's direct holdings in the company amount to 30,099 shares of common stock. The sale took place through an open market transaction, as reported in the company's latest filing.
2024年6月26日，維康倍特製藥（Vertex Pharmaceuticals Inc.，簡稱VRTX）的執行副總裁兼首席營銷官Carmen Bozic出售了2,280股普通股。該交易以471.72美元的價格執行，總銷售價值爲1,075,521.60美元。銷售後，Bozic在公司的直接持股總數爲30,099股普通股。這筆交易是通過公開市場交易進行的，如公司最新提交的申報所述。
2024年6月26日，維康倍特製藥（Vertex Pharmaceuticals Inc.，簡稱VRTX）的執行副總裁兼首席營銷官Carmen Bozic出售了2,280股普通股。該交易以471.72美元的價格執行，總銷售價值爲1,075,521.60美元。銷售後，Bozic在公司的直接持股總數爲30,099股普通股。這筆交易是通過公開市場交易進行的，如公司最新提交的申報所述。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。